APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,180 | -99.3% | 2,949 | -98.4% | 0.00% | -98.8% |
| Q2 2023 | $16,579,745 | +37.9% | 181,995 | -0.1% | 0.08% | +32.8% |
| Q1 2023 | $12,020,814 | +12.7% | 182,244 | -11.6% | 0.06% | +10.3% |
| Q4 2022 | $10,665,860 | +16.3% | 206,263 | +53.6% | 0.06% | +26.1% |
| Q3 2022 | $9,173,000 | +48.6% | 134,302 | -1.6% | 0.05% | +58.6% |
| Q2 2022 | $6,172,000 | +76.6% | 136,499 | +98.4% | 0.03% | +163.6% |
| Q1 2022 | $3,495,000 | +312.6% | 68,783 | +364.4% | 0.01% | +450.0% |
| Q4 2020 | $847,000 | +216.0% | 14,811 | +48.1% | 0.00% | +100.0% |
| Q1 2020 | $268,000 | -41.6% | 10,000 | -33.3% | 0.00% | -50.0% |
| Q4 2019 | $459,000 | -38.6% | 15,000 | -51.6% | 0.00% | -33.3% |
| Q3 2019 | $747,000 | +882.9% | 31,000 | +933.3% | 0.00% | – |
| Q2 2019 | $76,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |